We are live on ! Find out more
IDIX

IDENIX PHARMACEUTICALS INC
IDIX

Delisted

IDIX was delisted on the 5th of August, 2014.

Back to rankings

0 hedge funds and large institutions have $0 invested in IDENIX PHARMACEUTICALS INC in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 130 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 131 → 0 (-131)

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $2.78B → $0 (-$2.78B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 130

Holders
–
Holders Change
-131
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
130
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
BG
Baupost Group
Massachusetts
-$1.27B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$173M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$123M
4
BFA
BlackRock Fund Advisors
California
-$106M
5
BIT
BlackRock Institutional Trust
California
-$88.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
101
TFS Capital
Pennsylvania
– -$365K -15,147 Closed
O
102
OppenheimerFunds
New York
– -$340K -14,127 Closed
Citadel Advisors
103
Citadel Advisors
Florida
– -$339K -14,069 Closed
TD Asset Management
104
TD Asset Management
Ontario, Canada
– -$313K -13,000 Closed
Capstone Investment Advisors
105
Capstone Investment Advisors
New York
– -$301K -12,500 Closed
AIP
106
Ameritas Investment Partners
Nebraska
– -$254K -10,531 Closed
VFA
107
Virtus Fund Advisers
Connecticut
– -$242K -10,028 Closed
Two Sigma Advisers
108
Two Sigma Advisers
New York
– -$241K -10,012 Closed
AA
109
Ancora Advisors
Ohio
– -$241K -10,000 Closed
PP
110
Paloma Partners
Connecticut
– -$241K -10,000 Closed
AB
111
Amalgamated Bank
New York
– -$234K -9,696 Closed
N
112
Nuveen
North Carolina
– -$228K -9,481 Closed
Bank of America
113
Bank of America
North Carolina
– -$221K -9,139 Closed
PA
114
Profund Advisors
Maryland
– -$214K -8,880 Closed
Wells Fargo
115
Wells Fargo
California
– -$203K -8,423 Closed
CPA
116
Cowen Prime Advisors
New York
– -$193K -8,000 Closed
SEC
117
Seven Eight Capital
New York
– -$140K -5,800 Closed
Bank of Montreal
118
Bank of Montreal
Ontario, Canada
– -$68K -2,810 Closed
BlackRock
119
BlackRock
New York
– -$65K -2,695 Closed
Teacher Retirement System of Texas
120
Teacher Retirement System of Texas
Texas
– -$61K -2,532 Closed
Dimensional Fund Advisors
121
Dimensional Fund Advisors
Texas
– -$59K -2,429 Closed
Canada Life
122
Canada Life
Manitoba, Canada
– -$49K -2,031 Closed
Royal Bank of Canada
123
Royal Bank of Canada
Ontario, Canada
– -$48K -2,000 Closed
BJ
124
BlackRock Japan
Japan
– -$46K -1,924 Closed
BNP Paribas Financial Markets
125
BNP Paribas Financial Markets
France
– -$28.2K -1,170 Closed
2 3 4
5
6

IDIX Hedge Fund Activity: Q3 2014 in Review

0 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in IDENIX PHARMACEUTICALS INC (IDIX) for Q3 2014, worth a combined $0 — down 100% from $2.78B a quarter earlier.

Sellers outnumbered buyers: 130 funds closed out of IDIX and 0 opened new positions — a net loss of 130 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Baupost Group, exiting entirely with an estimated $1.27B sold.

  • 0 institutional investors held IDENIX PHARMACEUTICALS INC (IDIX) as of Q3 2014, down from 131 in Q2 2014.
  • Funds reported $0 of IDENIX PHARMACEUTICALS INC stock for Q3 2014, down 100% quarter-over-quarter.
  • 0 funds opened new IDENIX PHARMACEUTICALS INC positions in Q3 2014 and 130 closed out, a net change of -130 holders.
  • The largest IDENIX PHARMACEUTICALS INC seller in Q3 2014 was Baupost Group, an estimated $1.27B sold.

Based on aggregated 13F filings for Q3 2014.